- Australia Slashes Growth, Surplus Forecasts
- Stocks Rise as Asia Awaits US Election Outcome
- Bogle: Market Fundamentals Have 'Improved Radically'
- Dell Taking Further Steps To Cut Staff and Costs
- Marvel Posts Marvel-ous Profits, Sees Modest 2009
- Consumer Bankruptcies Soar in October
- Why the US Market Rallied Even Before Vote Was Over
- Fiscal Boost Needed to Lift Economy: Fed's Fisher
- World Closely Watching US Election
- Lightning Round: Cisco, Morgan Stanley, Bristol-Myers and More
- Cramer's Outrage: The U.S. Treasury
- Cramer's Case for CAT
- Your First Move For Wednesday November 5th
- Why Staples Is the Superior Stock
- Web Extra: Fast & Furious Trades For Wednesday
- Cramer: Time to Take Profits?
- More Behind the Scenes at McCain Headquarters
- Strategy Session with Jim Cramer and the Traders
- Papa John's revises full-year profit outlook
- Cessna to cut production amid financial crisis
- Deutsche Boerse 3Q profit increases 8 percent
- Ex-Bear Stearns risk officer gets job at Fed
- Papa John's 3Q profit climbs 40 percent
- Report: US News to go monthly, focus on online
- Boston Beer slashes 2008 outlook on recall costs
- Boston Beer swings to 3rd-qtr loss as costs rise
- Equity One posts rise in funds from operations
- Mannatech says SEC inquiry ends without action
NEW YORK - Shares of pharmacy-benefits manager Express Scripts Inc. jumped Friday after the company said its third-quarter profit surged, prompting a boost to its 2008 profit expectations and beyond.
The stock rose $4.54, or 7.9 percent, to $62.24 in afternoon trading. Shares have traded between $48.37 and $79.10 over the last 52 weeks.
Late Thursday, the St. Louis-based company said third-quarter profit rose 41 percent on increased use of generic drugs, topping Wall Street forecasts. The generic drug usage rate rose to 66.2 percent from 62.2 percent.
Meanwhile, the company boosted its 2008 profit outlook to between $3.07 and $3.10 per share, compared with a previous outlook for profit of $3.03 to $3.10 per share. Analysts polled by Thomson Reuters expect a profit of $3.07 per share, on average. Looking further ahead, the company expects 2009 profit between $3.63 to $3.73 per share, while analysts project profit of $3.63 per share.
"Despite an increasingly challenging economy and rising unemployment, Express Scripts delivered another positive earnings surprise," said Leerink Swann & Co. analyst Bret Jones, in a note to investors.
He reaffirmed a "Outperform" rating, saying company's success in driving generic use continues to drive margin expansion.
Cowen and Co. analyst Kemp Dolliver also reaffirmed a "Outperform" rating.

